Chakkarin Burudpakdee

Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States

Nina Kim, Jessie Wang, Chakkarin Burudpakdee et al. · Journal of Managed Care & Specialty Pharmacy · 2022 · 70 citations · Full text

Costs of Tumor Necrosis Factor Blockers Per Treated Patient Using Real-World Drug Data in a Managed Care Population

Vernon F. Schabert, Crystal Watson, George J Joseph et al. · Journal of Managed Care Pharmacy · 2013 · 63 citations · Full text

Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US

Linda Kalilani, Edward Faught, Hyunmi Kim et al. · Neurology · 2019 · 59 citations · Full text

Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer

Chakkarin Burudpakdee, William B. Wong, Arpamas Seetasith et al. · Lung Cancer · 2018 · 33 citations · Full text

Adherence and persistence in patients with type 2 diabetes mellitus newly initiating canagliflozin, dapagliflozin, dpp-4s, or glp-1s in the United States

Jennifer Cai, Victoria Divino, Chakkarin Burudpakdee · Current Medical Research and Opinion · 2017 · 31 citations